Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.
MGRX stock has fallen by 1.85% compared to the previous week, the month change is a 28.64% rise, over the last year Mangoceuticals, Inc. has showed a 74.76% decrease.
MGRX net income for the last quarter is −2.57 M USD, while the quarter before that showed −1.80 M USD of net income which accounts for −42.71% change. Track more Mangoceuticals, Inc. financial stats to get the full picture.
No, MGRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MGRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mangoceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MGRX reached its all-time high on Mar 21, 2023 with the price of 4.3700 USD, and its all-time low was 0.1430 USD and was reached on Mar 13, 2024. See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 3.00 employees. See our rating of the largest employees — is Mangoceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mangoceuticals, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mangoceuticals, Inc. stock shows the buy signal. See more of Mangoceuticals, Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mangoceuticals, Inc. EBITDA is −9.19 M USD, and current EBITDA margin is −1.26 K%. See more stats in Mangoceuticals, Inc. financial statements.